NEW YORK ( TheStreet) -- Regeneron Pharmaceuticals (Nasdaq: REGN) hit a new 52-week high Monday as it is currently trading at $119.58, above its previous 52-week high of $119.41 with 50,811 shares traded as of 9:35 a.m. ET. Average volume has been 1.4 million shares over the past 30 days. Regeneron has a market cap of $7.18 billion and is part of the health care sector and drugs industry. Shares are up 115% year to date as of the close of trading on Friday. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of serious medical conditions in the United States.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter